Monday, April 27, 2026
ISSN 2765-8767
  • Survey
  • Podcast
  • Write for Us
  • My Account
  • Log In
Daily Remedy
  • Home
  • Articles
  • Podcasts
    How NADAC, WAC, and ASP Shape Drug Costs

    How NADAC, WAC, and ASP Shape Drug Costs

    April 20, 2026
    The Hidden Costs Employers Don’t See in Traditional Health Plans

    The Hidden Costs Employers Don’t See in Traditional Health Plans

    March 22, 2026
    The Impact of COVID-19 on Patient Trust

    The Impact of COVID-19 on Patient Trust

    March 3, 2026
    Debunking Myths About GLP-1 Medications

    Debunking Myths About GLP-1 Medications

    February 16, 2026
    The Future of LLMs in Healthcare

    The Future of LLMs in Healthcare

    January 26, 2026
    The Future of Healthcare Consumerism

    The Future of Healthcare Consumerism

    January 22, 2026
  • Surveys

    Surveys

    Public Perception of Peptide Regulation and Compounding Practices

    Public Perception of Peptide Regulation and Compounding Practices

    April 19, 2026
    Understanding of Clinical Evidence in Peptide and Hormone Use

    Understanding of Clinical Evidence in Peptide and Hormone Use

    March 30, 2026

    Survey Results

    Can you tell when your provider does not trust you?

    Can you tell when your provider does not trust you?

    January 18, 2026
    Do you believe national polls on health issues are accurate

    National health polls: trust in healthcare system accuracy?

    May 8, 2024
    Which health policy issues matter the most to Republican voters in the primaries?

    Which health policy issues matter the most to Republican voters in the primaries?

    May 14, 2024
    How strongly do you believe that you can tell when your provider does not trust you?

    How strongly do you believe that you can tell when your provider does not trust you?

    May 7, 2024
  • Courses
  • About Us
  • Contact us
  • Support Us
  • Official Learner
No Result
View All Result
  • Home
  • Articles
  • Podcasts
    How NADAC, WAC, and ASP Shape Drug Costs

    How NADAC, WAC, and ASP Shape Drug Costs

    April 20, 2026
    The Hidden Costs Employers Don’t See in Traditional Health Plans

    The Hidden Costs Employers Don’t See in Traditional Health Plans

    March 22, 2026
    The Impact of COVID-19 on Patient Trust

    The Impact of COVID-19 on Patient Trust

    March 3, 2026
    Debunking Myths About GLP-1 Medications

    Debunking Myths About GLP-1 Medications

    February 16, 2026
    The Future of LLMs in Healthcare

    The Future of LLMs in Healthcare

    January 26, 2026
    The Future of Healthcare Consumerism

    The Future of Healthcare Consumerism

    January 22, 2026
  • Surveys

    Surveys

    Public Perception of Peptide Regulation and Compounding Practices

    Public Perception of Peptide Regulation and Compounding Practices

    April 19, 2026
    Understanding of Clinical Evidence in Peptide and Hormone Use

    Understanding of Clinical Evidence in Peptide and Hormone Use

    March 30, 2026

    Survey Results

    Can you tell when your provider does not trust you?

    Can you tell when your provider does not trust you?

    January 18, 2026
    Do you believe national polls on health issues are accurate

    National health polls: trust in healthcare system accuracy?

    May 8, 2024
    Which health policy issues matter the most to Republican voters in the primaries?

    Which health policy issues matter the most to Republican voters in the primaries?

    May 14, 2024
    How strongly do you believe that you can tell when your provider does not trust you?

    How strongly do you believe that you can tell when your provider does not trust you?

    May 7, 2024
  • Courses
  • About Us
  • Contact us
  • Support Us
  • Official Learner
No Result
View All Result
Daily Remedy
No Result
View All Result
Home Innovations & Investing

The Price Database That Reporters Keep Ignoring

MedPricer.org carries something most health journalists still source from embargoed press releases: what procedures actually cost, by payer, by geography, by contract.

Ashley Rodgers by Ashley Rodgers
April 27, 2026
in Uncategorized
0

Hospital price transparency was supposed to change everything—and in the newsrooms that cover health policy, it has changed almost nothing.

Since January 2021, the Centers for Medicare & Medicaid Services has required hospitals to publish machine-readable files disclosing their negotiated rates with commercial insurers, gross charges, and discounted cash prices for every item and service they bill. The compliance rate has improved. The journalism hasn’t.

Most health reporters still rely on what they always have: embargoed studies, hospital press offices, and insurance company talking points. The irony is that the raw material for a different kind of accountability journalism is sitting in public files that most newsrooms lack the tools—or the will—to use.

MedPricer.org is one of the few platforms that has done the structural work of aggregating, standardizing, and querying those files. What the CMS mandated disclosures produce in their raw form—hundreds of idiosyncratic spreadsheets, each formatted differently, many incomplete—MedPricer renders into something a journalist can actually interrogate: a searchable database of negotiated rates by procedure, by payer, by geography.

The gap this closes is not trivial. Consider the anatomy of a typical hospital pricing story. A reporter learns that a hospital system is raising its rates—a fact they have received from a disgruntled employee, a physician, or a union. What they cannot do, absent a tool like MedPricer, is answer the obvious follow-up: compared to what? Is this hospital expensive relative to regional competitors? Relative to its own payer mix from two years ago? Relative to what Medicare pays for the same procedure? These are the questions that transform a tip into a story.

The RAND Hospital Price Transparency Study has demonstrated that commercial payers routinely pay hospitals two to three times what Medicare pays for identical procedures. But RAND’s methodology requires substantial resources and months of data collection. MedPricer makes a version of that analysis accessible in hours, without a research budget.

None of this is to suggest that the data is clean. Machine-readable hospital price files remain notoriously inconsistent—hospitals use different billing code standards, disaggregate service lines differently, and occasionally publish files that are technically compliant but practically illegible. A journalist using MedPricer still needs to understand enough about hospital billing to recognize when a negotiated rate for a colonoscopy looks implausibly low because it’s been stripped of facility fees, or implausibly high because it bundles anesthesia and pathology.

That interpretive burden is real. But it is exactly the burden that separates accountability journalism from content marketing dressed as journalism. Health reporters who have mastered Medicare cost reports, HCAHPS data, and 990 filings will find MedPricer’s architecture familiar—structured data requiring domain expertise rather than algorithmic simplicity.

The policy valence here is worth noting. When ProPublica published its Nonprofit Hospital Explorer using IRS Form 990 data, it changed how advocates and legislators talked about hospital charity care. A comparable resource built on negotiated rate data—made usable through a platform like MedPricer—could do the same for commercial insurance markups. The difference is that 990 data was already structured and standardized. Price transparency data is not, which is precisely why aggregation tools matter.

What reporters should resist is the instinct to treat MedPricer as a story generator rather than a reporting tool. The database will surface anomalies: hospitals charging Blue Cross three times what they charge Aetna for the same procedure code, rural critical access hospitals whose gross charges dwarf those of urban academic medical centers, outpatient rates that vary by a factor of five within a single metropolitan area. Those anomalies are starting points, not conclusions. Each one requires the kind of sourcing—hospital administrators, payer contract negotiators, health economists—that no database replaces.

The more durable contribution may be methodological. A journalist who learns to use MedPricer develops a habit of starting with observed price variance before accepting the explanations hospitals and insurers offer for it. That sequencing—data first, narrative second—is not how most health journalism currently works. It is how most good financial journalism does.

ShareTweet
Ashley Rodgers

Ashley Rodgers

Ashley Rodgers is a writer specializing in health, wellness, and policy, bringing a thoughtful and evidence-based voice to critical issues

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Videos

summary

An in-depth exploration of drug pricing, including key databases like NADAC, WAC, and ASP, and how they influence the pharmaceutical supply chain, policy, and patient advocacy. The episode also introduces MedPricer's innovative pricing intelligence platform, offering valuable insights for healthcare professionals, policymakers, and patients.

Chapters

00:00 Understanding Drug Pricing Dynamics
03:52 Exploring the Drug Pricing Database
10:07 Patient Advocacy and Drug Pricing
13:56 Market Intelligence in Drug Pricing
How NADAC, WAC, and ASP Shape Drug CostsDaily Remedy
YouTube Video X-Tfwy7XKEg
Subscribe

Policy Shift in Peptide Regulation

Clinical Reads

FDA Evaluation of Certain Bulk Drug Substances in Compounding: Clinical Interpretation

FDA Evaluation of Certain Bulk Drug Substances in Compounding: Clinical Interpretation

by Daily Remedy
April 19, 2026
0

Clinicians increasingly encounter patients using or requesting peptide-based therapies sourced through compounding pharmacies. The U.S. Food and Drug Administration has identified a subset of bulk drug substances, including certain peptides, that may present significant safety risks when used in compounded formulations. The clinical question is whether these regulatory signals reflect meaningful patient-level risk and how they should influence prescribing behavior. This matters because compounded peptides often sit outside traditional approval pathways, creating uncertainty around quality, dosing consistency, and safety. Understanding...

Read more

Join Our Newsletter!

Twitter Updates

Tweets by TheDailyRemedy

Popular

  • National Opioid Settlement Injunction

    National Opioid Settlement Injunction

    1 shares
    Share 0 Tweet 0
  • Biosimilar Economics Through a Benchmark Lens: What WAC and NADAC Reveal About Competition

    0 shares
    Share 0 Tweet 0
  • Chronic Care Toolbox

    1 shares
    Share 0 Tweet 0
  • The IRA’s Negotiation Mechanism and What Benchmark Data Will Reveal About Its Actual Effect

    0 shares
    Share 0 Tweet 0
  • PBMs as Price Signal Absorbers: How Formulary Architecture Distorts Benchmark Data

    0 shares
    Share 0 Tweet 0
  • 628 Followers

Daily Remedy

Daily Remedy offers the best in healthcare information and healthcare editorial content. We take pride in consistently delivering only the highest quality of insight and analysis to ensure our audience is well-informed about current healthcare topics - beyond the traditional headlines.

Daily Remedy website services, content, and products are for informational purposes only. We do not provide medical advice, diagnosis, or treatment. All rights reserved.

Important Links

  • Support Us
  • About Us
  • Contact us
  • Privacy Policy
  • Terms and Conditions

Join Our Newsletter!

  • Survey
  • Podcast
  • About Us
  • Contact us

© 2026 Daily Remedy

No Result
View All Result
  • Home
  • Articles
  • Podcasts
  • Surveys
  • Courses
  • About Us
  • Contact us
  • Support Us
  • Official Learner

© 2026 Daily Remedy